136 related articles for article (PubMed ID: 9103527)
1. Video-microscopic assessment of the role of tissue angiotensin-converting enzyme in the control of the renal microcirculation.
ter Wee PM; Forster HG; Epstein M
J Pharmacol Exp Ther; 1997 Apr; 281(1):434-9. PubMed ID: 9103527
[TBL] [Abstract][Full Text] [Related]
2. The role of intrarenal prostaglandins and angiotensin II in acute cyclosporine-induced vasoconstriction.
Abraham JS; Bentley FR; Garrison RN
Surgery; 1991 Aug; 110(2):343-9. PubMed ID: 1858042
[TBL] [Abstract][Full Text] [Related]
3. EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles.
Ohishi K; Carmines PK; Inscho EW; Navar LG
Am J Physiol; 1992 Nov; 263(5 Pt 2):F900-6. PubMed ID: 1332506
[TBL] [Abstract][Full Text] [Related]
4. Cellular mechanisms mediating rat renal microvascular constriction by angiotensin II.
Takenaka T; Suzuki H; Fujiwara K; Kanno Y; Ohno Y; Hayashi K; Nagahama T; Saruta T
J Clin Invest; 1997 Oct; 100(8):2107-14. PubMed ID: 9329977
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II-mediated constriction of afferent and efferent arterioles involves T-type Ca2+ channel activation.
Feng MG; Navar LG
Am J Nephrol; 2004; 24(6):641-8. PubMed ID: 15627720
[TBL] [Abstract][Full Text] [Related]
6. Transient receptor potential channels in rat renal microcirculation: actions of angiotensin II.
Takenaka T; Suzuki H; Okada H; Inoue T; Kanno Y; Ozawa Y; Hayashi K; Saruta T
Kidney Int; 2002 Aug; 62(2):558-65. PubMed ID: 12110018
[TBL] [Abstract][Full Text] [Related]
7. Changes in angiotensin converting enzyme activity in the renal vascular bed of streptozotocin-induced diabetic rat.
Kamata K; Mizutani K
Res Commun Mol Pathol Pharmacol; 1999; 104(2):181-92. PubMed ID: 10634311
[TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney.
Loutzenhiser R; Hayashi K; Epstein M
J Pharmacol Exp Ther; 1988 Aug; 246(2):522-8. PubMed ID: 2969977
[TBL] [Abstract][Full Text] [Related]
9. Arteriolar constriction and local renin-angiotensin system in rat microcirculation.
Vicaut E; Hou X
Hypertension; 1993 Apr; 21(4):491-7. PubMed ID: 8384604
[TBL] [Abstract][Full Text] [Related]
10. Renal segmental microvascular responses to ANG II in AT1A receptor null mice.
Harrison-Bernard LM; Cook AK; Oliverio MI; Coffman TM
Am J Physiol Renal Physiol; 2003 Mar; 284(3):F538-45. PubMed ID: 12429556
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the renal microvascular effects of angiotensin II antagonist, DuP 753: studies in isolated perfused hydronephrotic kidneys.
Loutzenhiser R; Epstein M; Hayashi K; Takenaka T; Forster H
Am J Hypertens; 1991 Apr; 4(4 Pt 2):309S-314S. PubMed ID: 1854457
[TBL] [Abstract][Full Text] [Related]
12. Acute cyclosporine-induced renal vasoconstriction is mediated by endothelin-1.
Bloom IT; Bentley FR; Garrison RN
Surgery; 1993 Aug; 114(2):480-7; discussion 487-8. PubMed ID: 8342150
[TBL] [Abstract][Full Text] [Related]
13. Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney.
Ozawa Y; Hayashi K; Nagahama T; Fujiwara K; Saruta T
Hypertension; 2001 Sep; 38(3):343-7. PubMed ID: 11566902
[TBL] [Abstract][Full Text] [Related]
14. Visualisation of the effects of dilazep on rat afferent and efferent arterioles in vivo.
Nakamoto H; Ogasawara Y; Kajiya F
Hypertens Res; 2008 Feb; 31(2):315-24. PubMed ID: 18360052
[TBL] [Abstract][Full Text] [Related]
15. Segment-specific effect of chloride channel blockade on rat renal arteriolar contractile responses to angiotensin II.
Carmines PK
Am J Hypertens; 1995 Jan; 8(1):90-4. PubMed ID: 7734105
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of angiotensin and adenosine in the renal microvasculature.
Weihprecht H; Lorenz JN; Briggs JP; Schnermann J
Am J Physiol; 1994 Feb; 266(2 Pt 2):F227-39. PubMed ID: 8141324
[TBL] [Abstract][Full Text] [Related]
17. Location and action of angiotensin II type 1 receptor in the renal microcirculation.
Kimura K; Inokuchi S; Sugaya T; Suzuki N; Yoneda H; Shirato I; Mise N; Oba S; Miyashita K; Tojo A; Hirata Y; Goto A; Sakai T; Murakami K; Omata M
Kidney Int Suppl; 1997 Dec; 63():S201-4. PubMed ID: 9407459
[TBL] [Abstract][Full Text] [Related]
18. Impairment of afferent arteriolar myogenic responsiveness in the galactose-fed rat is prevented by tolrestat.
Forster HG; ter Wee PM; Hohman TC; Epstein M
Diabetologia; 1996 Aug; 39(8):907-14. PubMed ID: 8858212
[TBL] [Abstract][Full Text] [Related]
19. Renal arteriolar angiotensin responses during varied adenosine receptor activation.
Carmines PK; Inscho EW
Hypertension; 1994 Jan; 23(1 Suppl):I114-9. PubMed ID: 8282342
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
